FT Vest High Yield & Target Income ETF

HYTI · ETF

$18.32+$0.005 (+0.03%)TodayMarket closed ·
Prev close $18.31

About HYTI

HYTI was created on 2025-02-12 by FT Vest. The fund's investment portfolio concentrates primarily on income alternatives. The ETF currently has 83.45m in AUM and 3 holdings. HYTI is an actively managed fund that seeks to provide current income and capital appreciation through a synthetic long exposure to the iShares iBoxx High Yield Corporate Bond ETF (HYG) and a partial covered call strategy. It seeks an annual rate of approximately 5% over HYGs current annual yield.

Issuer
FT Vest
Expense ratio
0.65%
Assets under management
$83.20M
Inception
Feb 12, 2025
Asset class
Alternatives

HYTI key statistics

Price-earnings ratio
0.00
Average volume
60.46K
Volume
6.33K
Open price
$18.29
High today
$18.32
Low today
$18.29
52 Week high
$20.15
52 Week low
$18.13

FT Vest High Yield & Target Income ETF (HYTI) at a glance

As of Oct 23, 2026, FT Vest High Yield & Target Income ETF (HYTI) shares are priced at $18.32, giving the company a price-to-earnings ratio of 0.00.

Today the fund has traded between $18.29 and $18.32. The current price is 0.2% above the day's low and 0.0% below its high.

Volume so far is 6.33K shares, below the average of 60.46K shares a day.

Over the past year FT Vest High Yield & Target Income ETF has ranged from $18.13 to $20.15, and now sits 9% of the way up that range.

HYTI news

  • Press releaseBusiness Wire

    First Trust Expands Its Target Income ETFs® Lineup with the Launch of Three New Strategies

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.